Sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells

Published:2016-08 Issue:8 Volume:48 Page:e253-e253
ISSN:2092-6413
Container-title:Experimental & Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Hong Cheol Yi,Lee Hyun-Ju,Choi Nu-Ri,Jung Sung-Hoon,Vo Manh-Cuong,Hoang My Dung,Kim Hyeoung-Joon,Lee Je-Jung

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.nature.com/articles/emm201669.pdf

Reference43 articles.

1. Engleman EG . Dendritic cell-based cancer immunotherapy. Semin Oncol 2003; 30: 23–29.2.

2. Banchereau J, Palucka AK . Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005; 5: 296–306.

3. Banchereau J, Steinman RM . Dendritic cells and the control of immunity. Nature 1998; 392: 245–252.

4. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767–811.

5. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998; 28: 2760–2769.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering CaP-Pickering emulsion for enhanced mRNA cancer vaccines via dual DC and NK activations;Journal of Controlled Release;2024-09

2. Engineering W/O/W pickering emulsion for the enhanced antigen delivery and immune responses;Particuology;2024-09

3. Dendritic Cell‐Hitchhiking In Vivo for Vaccine Delivery to Lymph Nodes;Advanced Science;2024-07-04

4. Contribution of Heparan Sulphate Binding in CCL21-Mediated Migration of Breast Cancer Cells;Cancers;2021-07-10

5. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma;Cancer Immunology, Immunotherapy;2020-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3